FDA’s PREDICT Import Screening System Working As Predicted
This article was originally published in The Pink Sheet Daily
Executive Summary
An initial look at data from the first year of the import screening system’s full operation finds PREDICT is effective in directing FDA inspectors to high-risk products, Deputy Associate Commissioner for Regulatory Affairs Steve Solomon says.
You may also be interested in...
Pharma Import Alert: FDA Working Towards Consistency, Better Decision Making
FDA’s broad reorganization may not create the same super-specialization for the import staff that is coming to other parts of the agency, but a process overhaul appears on its way regardless.
Pharma Import Alert: FDA Working Towards Consistency, Better Decision Making
FDA’s broad reorganization may not create the same super-specialization for the import staff that is coming to other parts of the agency, but a process overhaul appears on its way regardless.
FDA Ready To Launch Secure Supply Chain Pilot
Program could allow for expedited entry of imports, but will be limited to 100 applicants and run for two years.